{"count": 21, "results": [{"_id": "33268288", "pmid": 33268288, "title": "Metformin decreased myocardial fibrosis and apoptosis in hyperhomocysteinemia -induced cardiac hypertrophy.", "journal": "Curr Res Transl Med", "authors": ["Zhao Q", "Song W", "Huang J", "Wang D", "Xu C"], "date": "2021-01-01T00:00:00Z", "doi": "10.1016/j.retram.2020.103270", "meta_date_publication": "2021 Jan", "meta_volume": "69", "meta_issue": "1", "meta_pages": "103270", "score": 50264.65, "text_hl": "However, whether @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ protects against @DISEASE_Hyperhomocysteinemia @DISEASE_MESH:D020138 @@@HHcy@@@-induced @<m>DISEASE_Cardiomegaly</m> @DISEASE_MESH:D006332 @@@cardiac hypertrophy@@@ is unclear. ", "citations": {"NLM": "Zhao Q, Song W, Huang J, Wang D, Xu C. Metformin decreased myocardial fibrosis and apoptosis in hyperhomocysteinemia -induced cardiac hypertrophy. Curr Res Transl Med. 2021 Jan;69(1):103270. PMID: 33268288", "BibTeX": "@article{33268288, title={Metformin decreased myocardial fibrosis and apoptosis in hyperhomocysteinemia -induced cardiac hypertrophy.}, author={Zhao Q and Song W and Huang J and Wang D and Xu C}, journal={Curr Res Transl Med}, volume={69}, number={1}, pages={103270}}"}}, {"_id": "36347344", "pmid": 36347344, "title": "Metformin induces a shift from glycolysis to fatty acid oxidation in cardiac hypertrophy via PHB1.", "journal": "Biochim Biophys Acta Gen Subj", "authors": ["Chakrabarti M", "Jain N", "Bhadra MP"], "date": "2023-02-01T00:00:00Z", "doi": "10.1016/j.bbagen.2022.130268", "meta_date_publication": "2023 Feb", "meta_volume": "1867", "meta_issue": "2", "meta_pages": "130268", "score": 50262.625, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ induces a shift from glycolysis to @CHEMICAL_Fatty_Acids @CHEMICAL_MESH:D005227 @@@fatty acid@@@ oxidation in @<m>DISEASE_Cardiomegaly</m> @DISEASE_MESH:D006332 @@@cardiac hypertrophy@@@ via @GENE_PHB @GENE_5245 @@@PHB1@@@.", "citations": {"NLM": "Chakrabarti M, Jain N, Bhadra MP. Metformin induces a shift from glycolysis to fatty acid oxidation in cardiac hypertrophy via PHB1. Biochim Biophys Acta Gen Subj. 2023 Feb;1867(2):130268. PMID: 36347344", "BibTeX": "@article{36347344, title={Metformin induces a shift from glycolysis to fatty acid oxidation in cardiac hypertrophy via PHB1.}, author={Chakrabarti M and Jain N and Bhadra MP}, journal={Biochim Biophys Acta Gen Subj}, volume={1867}, number={2}, pages={130268}}"}}, {"_id": "35833024", "pmid": 35833024, "pmcid": "PMC9271627", "title": "Metformin Attenuates Cardiac Hypertrophy Via the HIF-1alpha/PPAR-gamma Signaling Pathway in High-Fat Diet Rats", "journal": "Front Pharmacol", "authors": ["Liu Y", "Zhang Q", "Yang L", "Tian W", "Yang Y", "Xie Y", "Li J", "Yang L", "Gao Y", "Xu Y", "Liu J", "Wang Y", "Yan J", "Li G", "Shen Y", "Qi Z"], "date": "2022-06-27T00:00:00Z", "doi": "10.3389/fphar.2022.919202", "meta_date_publication": "2022", "meta_volume": "13", "meta_issue": "", "meta_pages": "919202", "score": 50256.758, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Attenuates @<m>DISEASE_Cardiomegaly</m> @DISEASE_MESH:D006332 @@@Cardiac Hypertrophy@@@ Via the @GENE_HIF1A @GENE_3091 @@@HIF-1alpha@@@/@GENE_PPARG @GENE_25664 @@@PPAR-gamma@@@ Signaling Pathway in High-Fat Diet Rats", "citations": {"NLM": "Liu Y, Zhang Q, Yang L, Tian W, Yang Y, Xie Y, Li J, Yang L, Gao Y, Xu Y, Liu J, Wang Y, Yan J, Li G, Shen Y, Qi Z. Metformin Attenuates Cardiac Hypertrophy Via the HIF-1alpha/PPAR-gamma Signaling Pathway in High-Fat Diet Rats Front Pharmacol. 2022;13():919202. PMID: 35833024", "BibTeX": "@article{35833024, title={Metformin Attenuates Cardiac Hypertrophy Via the HIF-1alpha/PPAR-gamma Signaling Pathway in High-Fat Diet Rats}, author={Liu Y and Zhang Q and Yang L and Tian W and Yang Y and Xie Y and Li J and Yang L and Gao Y and Xu Y and Liu J and Wang Y and Yan J and Li G and Shen Y and Qi Z}, journal={Front Pharmacol}, volume={13}, pages={919202}}"}}, {"_id": "35267651", "pmid": 35267651, "pmcid": "PMC8909901", "title": "Dual Effect of Combined Metformin and 2-Deoxy-D-Glucose Treatment on Mitochondrial Biogenesis and PD-L1 Expression in Triple-Negative Breast Cancer Cells", "journal": "Cancers (Basel)", "authors": ["Repas J", "Zupin M", "Vodlan M", "Veranič P", "Gole B", "Potočnik U", "Pavlin M"], "date": "2022-03-05T00:00:00Z", "doi": "10.3390/cancers14051343", "meta_date_publication": "2022 Mar 5", "meta_volume": "14", "meta_issue": "5", "meta_pages": "", "score": 50251.668, "text_hl": "Together with adequate energy stress, this was one of the possible triggers of @<m>DISEASE_Cardiomegaly</m> @DISEASE_MESH:D006332 @@@mitochondrial enlargement@@@. ", "citations": {"NLM": "Repas J, Zupin M, Vodlan M, Veranič P, Gole B, Potočnik U, Pavlin M. Dual Effect of Combined Metformin and 2-Deoxy-D-Glucose Treatment on Mitochondrial Biogenesis and PD-L1 Expression in Triple-Negative Breast Cancer Cells Cancers (Basel). 2022 Mar 5;14(5):. PMID: 35267651", "BibTeX": "@article{35267651, title={Dual Effect of Combined Metformin and 2-Deoxy-D-Glucose Treatment on Mitochondrial Biogenesis and PD-L1 Expression in Triple-Negative Breast Cancer Cells}, author={Repas J and Zupin M and Vodlan M and Veranič P and Gole B and Potočnik U and Pavlin M}, journal={Cancers (Basel)}, volume={14}, number={5}}"}}, {"_id": "34539827", "pmid": 34539827, "pmcid": "PMC8438677", "title": "Metformin attenuates angiotensin II-induced cardiomyocyte hypertrophy by upregulating the MuRF1 and MAFbx pathway", "journal": "Exp Ther Med", "authors": ["Du F", "Cao Y", "Ran Y", "Wu Q", "Chen B"], "date": "2021-11-01T00:00:00Z", "doi": "10.3892/etm.2021.10665", "meta_date_publication": "2021 Nov", "meta_volume": "22", "meta_issue": "5", "meta_pages": "1231", "score": 50250.38, "text_hl": "Taken together, data from the present study suggest that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ can prevent @<m>DISEASE_Cardiomegaly</m> @DISEASE_MESH:D006332 @@@cardiac hypertrophy@@@ through the @GENE_TRIM63 @GENE_140939 @@@MuRF1@@@ and @GENE_FBXO32 @GENE_171043 @@@MAFbx@@@ pathways.", "citations": {"NLM": "Du F, Cao Y, Ran Y, Wu Q, Chen B. Metformin attenuates angiotensin II-induced cardiomyocyte hypertrophy by upregulating the MuRF1 and MAFbx pathway Exp Ther Med. 2021 Nov;22(5):1231. PMID: 34539827", "BibTeX": "@article{34539827, title={Metformin attenuates angiotensin II-induced cardiomyocyte hypertrophy by upregulating the MuRF1 and MAFbx pathway}, author={Du F and Cao Y and Ran Y and Wu Q and Chen B}, journal={Exp Ther Med}, volume={22}, number={5}, pages={1231}}"}}, {"_id": "34384564", "pmid": 34384564, "title": "Metformin suppresses phenylephrine-induced hypertrophic responses by inhibiting p300-HAT activity in cardiomyocytes.", "journal": "J Pharmacol Sci", "authors": ["Sunagawa Y", "Shimizu K", "Katayama A", "Funamoto M", "Shimizu K", "Nurmila S", "Shimizu S", "Miyazaki Y", "Katanasaka Y", "Hasegawa K", "Morimoto T"], "date": "2021-10-01T00:00:00Z", "doi": "10.1016/j.jphs.2021.07.001", "meta_date_publication": "2021 Oct", "meta_volume": "147", "meta_issue": "2", "meta_pages": "169-175", "score": 50245.703, "text_hl": "However, the potential effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on @<m>DISEASE_Cardiomegaly</m> @DISEASE_MESH:D006332 @@@cardiac hypertrophy@@@ are still unclear. ", "citations": {"NLM": "Sunagawa Y, Shimizu K, Katayama A, Funamoto M, Shimizu K, Nurmila S, Shimizu S, Miyazaki Y, Katanasaka Y, Hasegawa K, Morimoto T. Metformin suppresses phenylephrine-induced hypertrophic responses by inhibiting p300-HAT activity in cardiomyocytes. J Pharmacol Sci. 2021 Oct;147(2):169-175. PMID: 34384564", "BibTeX": "@article{34384564, title={Metformin suppresses phenylephrine-induced hypertrophic responses by inhibiting p300-HAT activity in cardiomyocytes.}, author={Sunagawa Y and Shimizu K and Katayama A and Funamoto M and Shimizu K and Nurmila S and Shimizu S and Miyazaki Y and Katanasaka Y and Hasegawa K and Morimoto T}, journal={J Pharmacol Sci}, volume={147}, number={2}, pages={169-175}}"}}, {"_id": "40538089", "pmid": 40538089, "title": "Cardiovascular outcome in 12-month-old male and female offspring of metformin-treated obese mice.", "journal": "J Physiol", "authors": ["Schoonejans JM", "Wilsmore P", "Mennitti LV", "Wong KK", "Ashmore TJ", "Garrud TAC", "Blackmore HL", "Patey OV", "Fernandez-Twinn DS", "Giussani DA", "Ozanne SE"], "date": "2025-06-19T00:00:00Z", "doi": "10.1113/JP288696", "meta_date_publication": "2025 Jun 19", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50242.95, "text_hl": "Male @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@-exposed offspring also showed @<m>DISEASE_Cardiomegaly</m> @DISEASE_MESH:D006332 @@@cardiomegaly@@@, increased cardiac collagen and vascular sympathetic hyperreactivity, suggesting @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ exposure worsened the cardiovascular phenotype. ", "citations": {"NLM": "Schoonejans JM, Wilsmore P, Mennitti LV, Wong KK, Ashmore TJ, Garrud TAC, Blackmore HL, Patey OV, Fernandez-Twinn DS, Giussani DA, Ozanne SE. Cardiovascular outcome in 12-month-old male and female offspring of metformin-treated obese mice. J Physiol. 2025 Jun 19;():. PMID: 40538089", "BibTeX": "@article{40538089, title={Cardiovascular outcome in 12-month-old male and female offspring of metformin-treated obese mice.}, author={Schoonejans JM and Wilsmore P and Mennitti LV and Wong KK and Ashmore TJ and Garrud TAC and Blackmore HL and Patey OV and Fernandez-Twinn DS and Giussani DA and Ozanne SE}, journal={J Physiol}}"}}, {"_id": "37800110", "pmid": 37800110, "pmcid": "PMC10548184", "title": "Metformin Reduces the Progression of Atherogenesis by Regulating the Sestrin2-mTOR Pathway in Obese and Diabetic Rats", "journal": "J Lipid Atheroscler", "authors": ["Sundararajan S", "Jayachandran I", "Pandey GK", "Venkatesan S", "Rajagopal A", "Gokulakrishnan K", "Balasubramanyam M", "Mohan V", "Manickam N"], "date": "2023-09-01T00:00:00Z", "doi": "10.12997/jla.2023.12.3.290", "meta_date_publication": "2023 Sep", "meta_volume": "12", "meta_issue": "3", "meta_pages": "290-306", "score": 50242.914, "text_hl": "However, the role of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in regulating the Sestrin-@GENE_MTOR @GENE_2475 @@@mTOR@@@ nexus via the @GENE_PRKAA1 @GENE_5562 @@@AMPK@@@ pathway, particularly in relation to the progression of @DISEASE_Atherosclerosis @DISEASE_MESH:D050197 @@@atherosclerosis@@@ and @<m>DISEASE_Cardiomegaly</m> @DISEASE_MESH:D006332 @@@cardiac hypertrophy@@@, remains unclear. ", "citations": {"NLM": "Sundararajan S, Jayachandran I, Pandey GK, Venkatesan S, Rajagopal A, Gokulakrishnan K, Balasubramanyam M, Mohan V, Manickam N. Metformin Reduces the Progression of Atherogenesis by Regulating the Sestrin2-mTOR Pathway in Obese and Diabetic Rats J Lipid Atheroscler. 2023 Sep;12(3):290-306. PMID: 37800110", "BibTeX": "@article{37800110, title={Metformin Reduces the Progression of Atherogenesis by Regulating the Sestrin2-mTOR Pathway in Obese and Diabetic Rats}, author={Sundararajan S and Jayachandran I and Pandey GK and Venkatesan S and Rajagopal A and Gokulakrishnan K and Balasubramanyam M and Mohan V and Manickam N}, journal={J Lipid Atheroscler}, volume={12}, number={3}, pages={290-306}}"}}, {"_id": "39253815", "pmid": 39253815, "title": "Metformin modulates microbiota and improves blood pressure and cardiac remodeling in a rat model of hypertension.", "journal": "Acta Physiol (Oxf)", "authors": ["Wimmer MI", "Bartolomaeus H", "Anandakumar H", "Chen CY", "Vecera V", "Kedziora S", "Kamboj S", "Schumacher F", "Pals S", "Rauch A", "Meisel J", "Potapenko O", "Yarritu A", "Bartolomaeus TUP", "Samaan M", "Thiele A", "Stürzbecher L", "Geisberger SY", "Kleuser B", "Oefner PJ", "Haase N", "Löber U", "Gronwald W", "Forslund-Startceva SK", "Müller DN", "Wilck N"], "date": "2024-09-10T00:00:00Z", "doi": "10.1111/apha.14226", "meta_date_publication": "2024 Sep 10", "meta_volume": "", "meta_issue": "", "meta_pages": "e14226", "score": 50242.895, "text_hl": "It significantly reduced systolic and diastolic blood @DISEASE_Pressure_Ulcer @DISEASE_MESH:D003668 @@@pressure@@@ and improved cardiac function, as measured by end-diastolic volume, E/A, and @DISEASE_Stroke @DISEASE_MESH:D020521 @@@stroke@@@ volume despite increased @<m>DISEASE_Cardiomegaly</m> @DISEASE_MESH:D006332 @@@cardiac hypertrophy@@@. @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ reduced @DISEASE_Inflammation @DISEASE_MESH:D007249 @@@cardiac inflammation@@@ by lowering macrophage infiltration and shifting macrophage subpopulations towards a less @DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammatory@@@ phenotype. ", "citations": {"NLM": "Wimmer MI, Bartolomaeus H, Anandakumar H, Chen CY, Vecera V, Kedziora S, Kamboj S, Schumacher F, Pals S, Rauch A, Meisel J, Potapenko O, Yarritu A, Bartolomaeus TUP, Samaan M, Thiele A, Stürzbecher L, Geisberger SY, Kleuser B, Oefner PJ, Haase N, Löber U, Gronwald W, Forslund-Startceva SK, Müller DN, Wilck N. Metformin modulates microbiota and improves blood pressure and cardiac remodeling in a rat model of hypertension. Acta Physiol (Oxf). 2024 Sep 10;():e14226. PMID: 39253815", "BibTeX": "@article{39253815, title={Metformin modulates microbiota and improves blood pressure and cardiac remodeling in a rat model of hypertension.}, author={Wimmer MI and Bartolomaeus H and Anandakumar H and Chen CY and Vecera V and Kedziora S and Kamboj S and Schumacher F and Pals S and Rauch A and Meisel J and Potapenko O and Yarritu A and Bartolomaeus TUP and Samaan M and Thiele A and Stürzbecher L and Geisberger SY and Kleuser B and Oefner PJ and Haase N and Löber U and Gronwald W and Forslund-Startceva SK and Müller DN and Wilck N}, journal={Acta Physiol (Oxf)}, pages={e14226}}"}}, {"_id": "35673756", "pmid": 35673756, "title": "[The 495th case: young female-hyperandrogenemia-severe insulin resistance].", "journal": "Zhonghua Nei Ke Za Zhi", "authors": ["Cui YY", "Jiajue JRZ", "Chen MP", "Lu L", "Yu M", "Wang LJ"], "date": "2022-06-01T00:00:00Z", "doi": "10.3760/cma.j.cn112138-20210730-00511", "meta_date_publication": "2022 Jun 1", "meta_volume": "61", "meta_issue": "6", "meta_pages": "703-707", "score": 50242.715, "text_hl": "A 22-year-old female has complained of @DISEASE_Hirsutism @DISEASE_MESH:D006628 @@@hirsutism@@@, @DISEASE_Acanthosis_Nigricans @DISEASE_MESH:D000052 @@@acanthosis nigricans@@@, @<m>DISEASE_Cardiomegaly</m> @DISEASE_MESH:D006332 @@@enlarged clitoris@@@, and @DISEASE_Dysmenorrhea @DISEASE_MESH:D004412 @@@menstrual disorders@@@ since puberty. ", "citations": {"NLM": "Cui YY, Jiajue JRZ, Chen MP, Lu L, Yu M, Wang LJ. [The 495th case: young female-hyperandrogenemia-severe insulin resistance]. Zhonghua Nei Ke Za Zhi. 2022 Jun 1;61(6):703-707. PMID: 35673756", "BibTeX": "@article{35673756, title={[The 495th case: young female-hyperandrogenemia-severe insulin resistance].}, author={Cui YY and Jiajue JRZ and Chen MP and Lu L and Yu M and Wang LJ}, journal={Zhonghua Nei Ke Za Zhi}, volume={61}, number={6}, pages={703-707}}"}}]}